S

Seawolf Therapeutics

HealthDNA Medicines

Seawolf Therapeutics is focused on advancing DNA medicines. The company aims to leverage its innovative technology to develop treatments that can significantly impact patient care.

Total raised
Undisclosed
tracked to date
Latest round
$100 Million
Nov 16, 2026
Known investors
1
led by Sanofi

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    $100 MillionNov 16, 2026

    Led by Sanofi

    Announcement ↗

Investors in Seawolf Therapeutics

Backers from this company's tracked funding rounds.

  • SSanofiLead investorVC firm

Seawolf Therapeutics in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile